DEFA14A: RxSight, Inc. to Hold Annual Stockholders Meeting on June 3, 2025

RxSight, Inc. will hold its annual meeting of stockholders on June 3, 2025, to elect directors, approve executive compensation, and ratify the appointment of Ernst & Young LLP as the independent auditor.

Summary

• RxSight, Inc. is holding its annual meeting of stockholders on Tuesday, June 3, 2025, at 8:00 AM Pacific Time.
• The meeting will be held live via the internet at www.proxydocs.com/RXST.
• Stockholders of record as of April 8, 2025, are eligible to vote.
• The agenda includes the election of three Class I directors (Ron Kurtz, M.D., J. Andy Corley, and Juliet Tammenoms Bakker) to serve until the 2028 annual meeting.
• Stockholders will also vote on an advisory basis regarding the compensation of named executive officers as detailed in the 2024 Summary Compensation Table.
• The final proposal is to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Board of Directors recommends a vote 'FOR' on all three proposals.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an annual meeting, with no particularly positive or negative implications. It's a neutral procedural update.

Positives

• The meeting provides an opportunity for stockholders to participate in key decisions regarding the company's governance.
• Stockholders can access proxy materials and vote online for convenience.

Future Outlook

The document outlines the standard agenda items for an annual stockholders meeting, focusing on governance and auditing matters for the upcoming fiscal year.

Industry Context

This is a standard annual meeting announcement, typical for publicly traded companies to ensure shareholder participation in key decisions.

Stakeholder Impact

• Shareholders have the opportunity to vote on key company matters.
• The outcome of the votes will influence the composition of the board and the selection of the independent auditor.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will proceed with the annual meeting on June 3, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Directors, Executive Compensation, Ernst & Young, Auditor, Voting, RxSight